Stem Cell Culture Recombinant Human Blood Serum Albumin HSA Almost No Endotoxin

Stem Cell Culture Recombinant Human Blood Serum Albumin HSA Almost No Endotoxin

Quick detail

1. CAS No.: 70024-90-7
2. Other Names: Recombinant HSA, rHSA, OsrHSA
3. EINECS No.: 274-272-6
4. Place of Origin: Wuhan, China (Mainland)
5. Brand Name: Oryzogen
6. Model Number: HYC002M01
7. Purity: Greater than 99 % as determined by SDS-PAGE
8. Storage and Handling: Stored at temperatures 2-8℃ for 48 months

Description

Endotoxin is a gram-negative bacterium in the cell wall of a component known as lipopolysaccharide. Lipopolysaccharide is toxic to the host. These toxic reactions mainly perform fever reaction, leukocyte reaction and endotoxin shock. Endotoxin is not a protein, so it is very heat-resistant. Its structure won't be broken down by heating at 100 ° C for 1 hour. Only in very special condition, by heating at 160 ° C for 2 to 4 hours or by boiling with strong alkali, strong acid or strong oxidizing agent for 30 minutes,it can be destroyed. Therefore, developing, manufacturing and marketing low endotoxin products are very necessary. Our OsrHSA endotoxin is less than 0.125 EU / mg.

Advantages

1. The chairman of Healthgen Biotech Professor Daichang.Yang is one of China's chief scientists. Professor Yang has rechieved the “Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province and Top 10 "Venture Eagle" entrepreneurs.

With years of effort, Healthgen Biotech has developed the State-of-the-Art platform called Oryz^HiExp, having high capacity to express no animal origin proteins and peptides in the rice endosperm cells.

2. Wuhan Healthgen Biotechnology Corp. is a private company founded in 2006. We specialize in molecular pharmaceutical technology research and high-tech innovation-oriented product development, which is developing, manufacturing and marketing a series of recombinant proteins and growth factors by rice endosperm platform. We have 400 square meters of research center, in which 30% of the research personnels have doctoral degree and major in different directions of the research and development. Healthgen Biotech has strong capability in developing a series of biological products.

3. Healthgen Biotech recombinant human serum albumin is free of animal origin, which effectively avoid any potential risk of animal bacteria, prions, virus and contagious protein disease.

Supplemental Description

Healthgen Biotech, always pay great attention to the original technological innovation and intellectual property protection, has the titles of “Hubei Province Molecular Pharmaceutical Engineering Research Center” and “Protein Purification Research Center”. The rice endosperm cell high expression technology platform and other core technology have applied and gained 13 domestic and international patents; and won the “2012 Hubei Provincial Science and technology invention Award”, “2013 National Science and Technology Invention Award and China Patent Excellence Award’. The project obtained the funding from the National Ministry of science and high technology “863 plan”, Major national science and technology plan “Major projects of new varieties of genetically modified organisms” and “Major projects for new drug discovery”, the National Development and Reform Commission “Pilot development of strategic emerging industries”, National Ministry of science and technology innovation fund and state and local plans for all kinds of talented people funding. In July 2015, Healthgen Biotech became a public company on the "China New OTCBB", a national share transfer system for SMEs and officially known as the National Equities Exchange and Quotations, which is the “first stock” of the plant-derived pharmaceutical in China and even the world.